Effectiveness of Dry Needling in Shortened Triceps Surae Muscle (DN-TS)
Primary Purpose
Trigger Point Pain, Myofascial, Myofascial Pain Syndrome
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Dry needling
Ischemic compression
Sponsored by
About this trial
This is an interventional treatment trial for Trigger Point Pain, Myofascial
Eligibility Criteria
Inclusion Criteria:
- Myofascial pain syndrome in the triceps surae muscle, limitation of ankle dorsal flexion range of motion.
Exclusion Criteria:
- Neurologic disorders, pharmacologic treatment (within the previous 3 months), cognitive impairment, prosthesis in the lower limb, systemic or infectious diseases, autoimmune diseases, fibromyalgia, hypothyroidism, anticoagulants or antiplatelet agents, and fear of needles.
Sites / Locations
- Fisiofuenla
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Dry needling
Ischemic compression
Arm Description
Outcomes
Primary Outcome Measures
Range of motion
Ankle dorsal flexion by means of the goniometer
Secondary Outcome Measures
Plantar pressures
Plantar pressures platform
Temperature
Thermal imaging
Superficial muscle activity
Electromyography
Pressure pain threshold
Algometer
Full Information
NCT ID
NCT03273985
First Posted
September 1, 2017
Last Updated
December 6, 2017
Sponsor
Universidad de León
Collaborators
Universidad Complutense de Madrid
1. Study Identification
Unique Protocol Identification Number
NCT03273985
Brief Title
Effectiveness of Dry Needling in Shortened Triceps Surae Muscle
Acronym
DN-TS
Official Title
Effectiveness of Deep Dry Needling in Subjects With Shortened Triceps Surae Originated by Myofascial Pain Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
September 15, 2017 (Actual)
Primary Completion Date
December 6, 2017 (Actual)
Study Completion Date
December 6, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad de León
Collaborators
Universidad Complutense de Madrid
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To date, there are not studies about the effectiveness of dry needling versus ischemic compression in the triceps surae trigger points. A randomized clinical trial is carried out. A sample of 30 subjects are recruited and allocated into dry needling (n = 15) and ischemic compression (n = 15). Outcome measurements such as dorsal flexion range of motion, plantar pressures, temperature, superficial muscle activity and trigger points pressure pain threshold are measured immediately before and after treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trigger Point Pain, Myofascial, Myofascial Pain Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dry needling
Arm Type
Experimental
Arm Title
Ischemic compression
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Dry needling
Intervention Description
Trigger point deep dry needling
Intervention Type
Other
Intervention Name(s)
Ischemic compression
Intervention Description
Trigger point ischemic compression
Primary Outcome Measure Information:
Title
Range of motion
Description
Ankle dorsal flexion by means of the goniometer
Time Frame
Change from Baseline Range of motion at 25 minutes
Secondary Outcome Measure Information:
Title
Plantar pressures
Description
Plantar pressures platform
Time Frame
Change from Baseline Plantar pressures at 25 minutes
Title
Temperature
Description
Thermal imaging
Time Frame
Change from Baseline Temperature at 25 minutes
Title
Superficial muscle activity
Description
Electromyography
Time Frame
Change from Baseline Superficial muscle activity at 25 minutes
Title
Pressure pain threshold
Description
Algometer
Time Frame
Change from Baseline Pressure pain threshold at 25 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Myofascial pain syndrome in the triceps surae muscle, limitation of ankle dorsal flexion range of motion.
Exclusion Criteria:
Neurologic disorders, pharmacologic treatment (within the previous 3 months), cognitive impairment, prosthesis in the lower limb, systemic or infectious diseases, autoimmune diseases, fibromyalgia, hypothyroidism, anticoagulants or antiplatelet agents, and fear of needles.
Facility Information:
Facility Name
Fisiofuenla
City
Fuenlabrada
State/Province
Madrid
ZIP/Postal Code
28943
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31502640
Citation
Benito-de-Pedro M, Becerro-de-Bengoa-Vallejo R, Elena Losa-Iglesias M, Rodriguez-Sanz D, Lopez-Lopez D, Palomo-Lopez P, Mazoteras-Pardo V, Calvo-Lobo AC. Effectiveness of Deep Dry Needling vs Ischemic Compression in the Latent Myofascial Trigger Points of the Shortened Triceps Surae from Triathletes on Ankle Dorsiflexion, Dynamic, and Static Plantar Pressure Distribution: A Clinical Trial. Pain Med. 2020 Feb 1;21(2):e172-e181. doi: 10.1093/pm/pnz222.
Results Reference
derived
Learn more about this trial
Effectiveness of Dry Needling in Shortened Triceps Surae Muscle
We'll reach out to this number within 24 hrs